Work of Breathing and Kangaroo Mother Care
The Impact of Kangaroo Mother Care on Work of Breathing Indices and Oxygen Saturation Stability in Very Low Birth Weight Infants
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Delaware
-
Newark, Delaware, United States, 19718
- Christiana Care Health Services, Inc
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Very low birth weight infants (those less than 1500g at birth)
- Respiratory insufficiency
- >4d PMA
- Stable and receiving non-invasive respiratory support for ≥12 hours (NC, HFNC or CPAP)
- Requiring ≤40% supplemental FiO2
Exclusion Criteria:
- Infants with skeletal, neuromuscular or abdominal surgical disorders that may affect the accuracy of work of breathing measurements
- Infants who do not meet criteria to participate in kangaroo mother care
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
all infants
There will be one arm for this study.
All infants will receive a similar intervention during their routine kangaroo mother care (KMC).
KMC is a national and international standard of care.
This is an observational study of how infants breath while participating in KMC compared to how they breath while in a crib or incubator.
Work of breathing will be measured at baseline and then during KMC.
Mothers will participate in KMC regardless of participation in the study.
Work of breathing will be measured by using Respiratory Inductance Plethysmography (RIP).
This scientifically measures work of breathing (specifically phase angles) by placing soft bands around the abdomen and chest.
The actual "intervention" is a standard of care and something that the mother infant dyad will do regardless of the study.
Each mother / infants pair is expected to be actively enrolled for approximately 2 hours.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in work of breathing
Time Frame: 2 hours
|
Work of breathing will be measured before, during, and after KMC.
Comparisons will be made.
|
2 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oxygen saturation
Time Frame: 2 hours
|
Oxygen saturations will be measured before, during, and after KMC.
Comparisons will be made.
|
2 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Kelley Kovatis, MD, Christiana Care Health Services
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- DDD603995
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.